Thermo Fisher Scientific/$TMO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Ticker
$TMO
Sector
Primary listing
NYSE
Employees
125,000
Headquarters
Website
TMO Metrics
BasicAdvanced
$214bn
31.21
$18.58
0.85
$1.80
0.32%
Price and volume
Market cap
$214bn
Beta
0.85
52-week high
$643.99
52-week low
$435.27
Average daily volume
2.3m
Dividend rate
$1.80
Financial strength
Current ratio
1.551
Quick ratio
0.897
Long term debt to equity
74.197
Total debt to equity
80.575
Dividend payout ratio (TTM)
9.50%
Interest coverage (TTM)
6.00%
Profitability
EBITDA (TTM)
11,739
Gross margin (TTM)
40.99%
Net profit margin (TTM)
15.04%
Operating margin (TTM)
18.98%
Effective tax rate (TTM)
7.88%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
5.13%
Return on equity (TTM)
13.52%
Valuation
Price to earnings (TTM)
31.212
Price to revenue (TTM)
4.682
Price to book
4.08
Price to tangible book (TTM)
-10.37
Price to free cash flow (TTM)
29.643
Free cash flow yield (TTM)
3.37%
Free cash flow per share (TTM)
19.567
Dividend yield (TTM)
0.31%
Forward dividend yield
0.32%
Growth
Revenue change (TTM)
7.23%
Earnings per share change (TTM)
7.45%
3-year revenue growth (CAGR)
2.11%
10-year revenue growth (CAGR)
10.16%
3-year earnings per share growth (CAGR)
8.28%
10-year earnings per share growth (CAGR)
14.03%
3-year dividend per share growth (CAGR)
11.46%
10-year dividend per share growth (CAGR)
11.61%
What the Analysts think about TMO
Analyst ratings (Buy, Hold, Sell) for Thermo Fisher Scientific stock.
TMO Financial Performance
Revenues and expenses
TMO Earnings Performance
Company profitability
TMO News
AllArticlesVideos
Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost
Reuters7 hours ago
Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026
Business Wire2 weeks ago
Thermo Fisher Scientific Launches Thermo Scientific™ InstaFlux™ to Help Food Microbiology Labs Simplify Workflows in Pathogen and Environmental Testing
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.